CLIA-tested genetic variants on commercial SNP arrays: potential for incidental findings in genome-wide association studies
- PMID: 20556870
- PMCID: PMC3056880
- DOI: 10.1097/GIM.0b013e3181e1e2a9
CLIA-tested genetic variants on commercial SNP arrays: potential for incidental findings in genome-wide association studies
Abstract
Purpose: Increases in throughput and affordability of genotyping products have led to large sample sizes in genetic studies, increasing the likelihood that incidental genetic findings may occur. We set out to survey potential notifiable variants on arrays used in genome-wide association studies and in direct-to-consumer genetic services.
Methods: We used multiple bioinformatics strategies to identify, and map variants tested for genetic disorders in > or = 2 CLIA-approved laboratories (based on the GeneTests database). We subsequently surveyed 18 commercial single nucleotide polymorphism arrays and HapMap for these variants.
Results: Of 1,362 genes tested according to GeneTests, we identified 298 specific targeted mutations measured in more than or equal to two laboratories, encompassing 56 disorders. Only 88 of 298 mutations could be identified as known single nucleotide polymorphisms in genomic databases. We found 18 of 88 single nucleotide polymorphisms present in HapMap or on commercial single nucleotide polymorphism arrays. Homozygotes for rare alleles of some variants were identified in the Framingham Heart Study, an active genome-wide association studies cohort (n = 8,410).
Conclusions: Variants in genes including APOE, F5, HFE, CYP21A2, MEFV, SPINK1, BTD, GALT, and G6PD were found on single nucleotide polymorphism arrays or in the HapMap. Some of these variants may warrant further review to determine their likelihood to trigger incidental findings in the course of genome-wide association studies or direct-to-consumer testing.
Conflict of interest statement
None of the authors have a conflict of interest to disclose.
Figures


Similar articles
-
Integration of HapMap-based SNP pattern analysis and gene expression profiling reveals common SNP profiles for cancer therapy outcome predictor genes.Cell Cycle. 2006 Nov;5(22):2613-25. doi: 10.4161/cc.5.22.3498. Epub 2006 Nov 15. Cell Cycle. 2006. PMID: 17172834
-
Design of tag SNP whole genome genotyping arrays.Methods Mol Biol. 2009;529:51-61. doi: 10.1007/978-1-59745-538-1_4. Methods Mol Biol. 2009. PMID: 19381970
-
Effect of genome-wide genotyping and reference panels on rare variants imputation.J Genet Genomics. 2012 Oct 20;39(10):545-50. doi: 10.1016/j.jgg.2012.07.002. Epub 2012 Jul 24. J Genet Genomics. 2012. PMID: 23089364
-
The extent of linkage disequilibrium and computational challenges of single nucleotide polymorphisms in genome-wide association studies.Curr Drug Metab. 2011 Jun;12(5):498-506. doi: 10.2174/138920011795495312. Curr Drug Metab. 2011. PMID: 21453276 Review.
-
HapMap and mapping genes for cardiovascular disease.Circ Cardiovasc Genet. 2008 Oct;1(1):66-71. doi: 10.1161/CIRCGENETICS.108.813675. Circ Cardiovasc Genet. 2008. PMID: 20031544 Free PMC article. Review.
Cited by
-
Evidence for extensive pleiotropy among pharmacogenes.Pharmacogenomics. 2016 Jun;17(8):853-66. doi: 10.2217/pgs-2015-0007. Epub 2016 Jun 1. Pharmacogenomics. 2016. PMID: 27249515 Free PMC article.
-
Three clinical experiences with SNP array results consistent with parental incest: a narrative with lessons learned.J Genet Couns. 2014 Aug;23(4):489-95. doi: 10.1007/s10897-013-9669-0. Epub 2013 Nov 13. J Genet Couns. 2014. PMID: 24222483
-
Individual genetic and genomic research results and the tradition of informed consent: exploring US review board guidance.J Med Ethics. 2012 Jul;38(7):417-22. doi: 10.1136/medethics-2011-100273. Epub 2012 Mar 5. J Med Ethics. 2012. PMID: 22361295 Free PMC article.
-
Disclosing pathogenic genetic variants to research participants: quantifying an emerging ethical responsibility.Genome Res. 2012 Mar;22(3):421-8. doi: 10.1101/gr.127845.111. Epub 2012 Jan 6. Genome Res. 2012. PMID: 22147367 Free PMC article.
-
70-year legacy of the Framingham Heart Study.Nat Rev Cardiol. 2019 Nov;16(11):687-698. doi: 10.1038/s41569-019-0202-5. Nat Rev Cardiol. 2019. PMID: 31065045 Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous